| 000 | 01117 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513180353.0 | ||
| 264 | 0 | _c19801024 | |
| 008 | 198010s 0 0 eng d | ||
| 022 | _a0012-6578 | ||
| 024 | 7 |
_a10.1177/106002808001400711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorris, L A | |
| 245 | 0 | 0 |
_aConsumer reactions to differing amounts of written drug information. _h[electronic resource] |
| 260 |
_bDrug intelligence & clinical pharmacy _c |
||
| 300 |
_a531-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aConsumer Behavior |
| 650 | 0 | 4 |
_aDrug Labeling _xstandards |
| 650 | 0 | 4 |
_aErythromycin _xadverse effects |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaryland |
| 650 | 0 | 4 |
_aPatient Education as Topic _xstandards |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aKanouse, D E | |
| 773 | 0 |
_tDrug intelligence & clinical pharmacy _gvol. 14 _gno. 7-8 _gp. 531-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/106002808001400711 _zAvailable from publisher's website |
| 999 |
_c10206821 _d10206821 |
||